Curis
CRIS
#11244
Rank
A$2.06 M
Marketcap
A$0.85
Share price
9.39%
Change (1 day)
-62.46%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -A$11.74 Million

According to Curis's latest financial reports the company's current earnings are A$4.31 Million. In 2025 the company made an earning of -A$7.68 Million, an increase over its 2024 earnings that were of -A$60.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$11.74 Million52.97%
2025 -A$7.68 Million-87.38%
2024 -A$60.8 Million-5.77%
2023 -A$64.53 Million-13.1%
2022 -A$74.25 Million27.52%
2021 -A$58.23 Million65.09%
2020 -A$35.27 Million-9.1%
2019 -A$38.8 Million-4.73%
2018 -A$40.73 Million-41.95%
2017 -A$70.15 Million-14.37%
2016 -A$81.93 Million3.55%
2015 -A$79.11 Million271.52%
2014 -A$21.3 Million76.64%
2013 -A$12.06 Million
2011 -A$10.24 Million27.76%
2010 -A$8.02 Million-43.87%
2009 -A$14.28 Million-23.44%
2008 -A$18.65 Million56.66%
2007 -A$11.91 Million-16.71%
2006 -A$14.3 Million-36.92%
2005 -A$22.66 Million156.25%
2004 -A$8.85 Million-37.24%
2003 -A$14.09 Million-93.34%
2002 -A$0.22 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.81 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.92 B-141,080.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$87.96 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.47 B-12,356.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.47 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$31.64 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA